Tag Archives: rosiglitazone
American Heart Association’s Defense of Avandia (Questionable Motives)
The always provocative blogger, Jim Edwards, who has historically printed some extremely insightful columns on the pharmaceutical industry, is at it again. This time, the motivations behind the American Heart Association’s suggestion that recent reports and findings that Avandia (Rosiglitazone) … Continue reading
Posted in Avandia
Tagged aha, american heart association, Avandia, cardiac risks, congestive heart failure, donations, heart attacks, rosiglitazone, strokes
Avandia Implicated as Causing Liver Damage
Aylstock, Witkin, Kreis & Overholtz is one of the lead plaintiffs’ firms in the country pursuing the national litigation effort against GlaxoSmithKline relating to its diabetes drug Avandia (rosiglitazone). The adverse events and injuries which have been associated with Avandia … Continue reading
Posted in Avandia
Tagged alt, ast, Avandia, hepatotoxic, hepatotoxicity, liver, liver function test, rosiglitazone